Scientific and Clinical Studies
Theralac® Probiotic Strains
References
Complimentary human strain synergistic with BL-34 – on deposit at the ATCC as SD5220.
1) Works in combination with LA-1 and BL-34 to reduce negative impact of antibiotics on
G.I. flora: J. Med. Microbiol., 2009, Vol. 58, pp 663-670.
2) Bi-07 has been characterized as B. lactis using PCR:
Appl. Environ. Microbiol., 2002, Vol. 68 (12), pp 6429-6434.
3) Bi-07 reduces intestinal inflammation and balances mucosal immune response:
World J. Gastroenterology, 2007, Vol. 13 (2), pp 236-243.
4) Bi-07 reduces Candida colonization and severity of candidiasis:
Infect. Immunol., 1997, Vol. 65, pp 4165-4172.
5) Bi-07 plus LA-1 decreased diarrhea in 120 children ages 12-36 mo. in a
double-blind, placebo controlled study: Pediatric Research, 1999, Vol. 39 (2), p 104.
6) Bi-07 significantly reduced upper respiratory infection symptoms in a
study involving 326 children: U.S. Provisional Patent Appl., 2006, No. 60/848,662.
Return to Scientific References